23andMe Gets OK to Sell Breast Cancer Gene Test: No Prescription Needed
Amazing Health Advances Subscribe to Amazing Health Advances

To receive daily emails from Amazing Health Advances to your inbox CLICK HERE

23andMe Gets OK to Sell Breast Cancer Gene Test: No Prescription Needed

Julie Steenhuysen — Reuters
Mar 8, 2018

Genetic testing company 23andMe on Tuesday won U.S. Food and Drug Administration approval to sell genetic tests for three key breast cancer mutations directly to consumers, a coup for the company that has been gradually winning approval for such tests after FDA banned its Personal Genome Service in 2013... continue reading.

Read Full Story Here


 

 

 

 





Amazing Health Advances